arrow
Back
J

Joshua Richter

icahn school of medicine at mount sinai

0H-index
2Paper Count
0Citation Count
Published Papers 2
Publication Date
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial
err2026-07-22
err0
errOAAI
errAdam D. Cohen; Joshua Richter; Suzanne Trudel; Alexander Lesokhin; Jacob P. Laubach; Sheeba K. Thomas; Simon J. Harrison; Luciano J. Costa; Andrew Spencer; Rafael Fonseca; Peter A. Forsberg; Jesus G. Berdeja; Rayan Kaedbey; Nizar J. Bahlis; Paula Rodriguez-Otero; Maria-Victoria Mateos; Tulika Tyagi; Divya Samineni; Wenyu Liu; Rin Nakamura; Voleak Choeurng; Chihunt Wong; James Cooper; Amrita Krishnan
errShare
errSave
Belantamab mafodotin for patients with multiple myeloma: clinical development and practical strategies for dose optimization and toxicity management
err2026-06-25
err0
PREAI
errRoberto Mina; Evangelos Terpos; Lorenzo Cani; Ajay Nooka; Suzanne Trudel; Peeter Voorhees; Hira Mian; Binod Dhakal; Saad Usmani; Joshua Richter; Rakesh Popat; Maria Victoria Mateos; Sagar Lonial
errShare
errSave